Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis

N Engl J Med. 2003 Dec 11;349(24):2334-9. doi: 10.1056/NEJMoa031261.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • CD4 Lymphocyte Count
  • Cytokines / blood
  • Dermatitis / drug therapy*
  • Dermatitis / immunology
  • Eosinophils
  • Female
  • Humans
  • Hypereosinophilic Syndrome / drug therapy*
  • Hypereosinophilic Syndrome / immunology
  • Infusions, Intravenous
  • Interleukin-5 / immunology*
  • Leukocyte Count
  • Middle Aged

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Cytokines
  • Interleukin-5
  • mepolizumab